<!DOCTYPE html>
<html lang="de">
<head>
  <meta charset="UTF-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0"/>
  <title>Neuroguard â€“ KI-Prognoseplattform</title>
  <link href="https://fonts.googleapis.com/css2?family=Montserrat:wght@400;600;700&display=swap" rel="stylesheet">
  <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css"/>
  <style>
    :root {
      --blue-light: #E3F2FD;
      --blue: #1E88E5;
      --blue-dark: #1565C0;
      --red: #E53935;
      --gray: #555;
      --white: #fff;
    }
    * { margin:0; padding:0; box-sizing:border-box; }
    body {
      font-family: 'Montserrat', sans-serif;
      background: #f5f7fa;
      color: #333;
      line-height: 1.6;
      overflow-x: hidden;
    }
    .deck { max-width: 1000px; margin: 20px auto; }
    .slide {
      background: var(--white);
      margin: 15px;
      padding: 40px;
      border-radius: 16px;
      box-shadow: 0 10px 30px rgba(0,0,0,0.1);
      min-height: 500px;
      position: relative;
      animation: fadeIn 0.6s ease-in;
    }
    @keyframes fadeIn { from {opacity:0; transform:translateY(20px);} to {opacity:1; transform:none;} }
    h1 { font-size: 2.8rem; color: var(--blue-dark); margin-bottom: 10px; }
    h2 { font-size: 2rem; color: var(--blue); margin: 20px 0 15px; }
    p { margin: 12px 0; font-size: 1.1rem; }
    ul { margin: 15px 0; padding-left: 30px; }
    li { margin: 8px 0; font-size: 1.1rem; }
    table {
      width: 100%;
      border-collapse: collapse;
      margin: 20px 0;
      font-size: 1rem;
    }
    th, td {
      padding: 12px 15px;
      text-align: left;
      border-bottom: 1px solid #eee;
    }
    th { background: var(--blue-light); color: var(--blue-dark); font-weight: 600; }
    tr:hover { background: #f8fbff; }
    .highlight { color: var(--red); font-weight: 700; }
    .badge {
      display: inline-block;
      padding: 5px 12px;
      border-radius: 20px;
      font-size: 0.9rem;
      font-weight: 600;
      margin: 5px 5px 5px 0;
    }
    .badge-green { background: #e8f5e9; color: #2e7d32; }
    .badge-red { background: #ffebee; color: var(--red); }
    .dashboard {
      background: #f9f9f9;
      padding: 20px;
      border-radius: 12px;
      border: 1px solid #ddd;
      margin: 20px 0;
      font-family: monospace;
    }
    .risk-high { color: var(--red); font-weight: bold; }
    .risk-med { color: #fb8c00; }
    .risk-low { color: #43a047; }
    .footer {
      text-align: center;
      padding: 20px;
      font-size: 0.9rem;
      color: #777;
      margin-top: 30px;
    }
    .nav {
      position: fixed;
      top: 20px;
      right: 20px;
      background: var(--blue);
      color: white;
      padding: 10px 15px;
      border-radius: 50px;
      font-size: 0.9rem;
      z-index: 100;
      box-shadow: 0 4px 12px rgba(0,0,0,0.2);
    }
    .nav a { color: white; text-decoration: none; margin: 0 8px; }
    .icon { font-size: 1.5rem; margin-right: 10px; vertical-align: middle; }
    .text-center { text-align: center; }
    .quote {
      font-style: italic;
      color: var(--gray);
      background: var(--blue-light);
      padding: 15px;
      border-radius: 12px;
      margin:: 20px 0;
      border-left: 5px solid var(--blue);
    }
    .chart-placeholder {
      background: #f0f0f0;
      height: 200px;
      border-radius: 12px;
      margin: 20px 0;
      display: flex;
      align-items: center;
      justify-content: center;
      color: #777;
      font-style: italic;
      border: 2px dashed #ccc;
    }
    @media (max-width: 768px) {
      .slide { padding: 20px; margin: 10px; }
      h1 { font-size: 2rem; }
      h2 { font-size: 1.6rem; }
    }
    .print-only { display: none; }
    @media print {
      .nav, .no-print { display: none; }
      .slide { page-break-after: always; margin: 0; box-shadow: none; }
      body { background: white; }
      .print-only { display: block; }
    }
  </style>
</head>
<body>

<div class="nav no-print">
  <a href="#slide1">1</a> |
  <a href="#slide2">2</a> |
  <a href="#slide3">3</a> |
  <a href="#slide4">4</a> |
  <a href="#slide5">5</a> |
  <a href="#slide6">6</a> |
  <a href="#slide7">7</a> |
  <a href="#slide8">8</a> |
  <a href="#slide9">9</a> |
  <a href="#slide10">10</a> |
  <a href="#slide11">11</a> |
  <a href="#slide12">12</a>
</div>

<div class="deck">

<!-- FOLIE 1 -->
<div class="slide" id="slide1">
  <h1 style="font-size:3.2rem; margin-bottom:15px;">NEUROGUARD</h1>
  <p style="font-size:1.4rem; color:var(--blue);">KI-basierte postoperative Prognoseplattform</p>
  <p style="font-size:1.6rem; margin:30px 0; color:var(--blue-dark);"><strong>FrÃ¼hwarnung. PrÃ¤zision. Leben retten.</strong></p>
  <hr style="border:1px solid var(--blue); width:100px; margin:30px 0;">
  <p><strong>Cemalettin G.</strong> â€“ Founder & CEO</p>
  <p><strong>Oktay T.</strong> â€“ Co-Founder & CTO</p>
  <p style="margin-top:20px;">ğŸ“§ cemalettin@neuroguard.ai<br>ğŸ“ +41 79 123 45 67</p>
  <div style="margin-top:40px; font-size:2rem; color:var(--blue);">
    <i class="fas fa-brain icon"></i><i class="fas fa-microchip icon"></i>
  </div>
</div>

<!-- FOLIE 2 -->
<div class="slide" id="slide2">
  <h1>Das Problem</h1>
  <p class="quote">"Jede 3. postoperative Komplikation in der Neurochirurgie wird <strong>zu spÃ¤t erkannt</strong>."</p>
  <ul>
    <li>âŒ Kritische <strong>ICP-VerlÃ¤ufe</strong> bleiben <strong>stundenlang unerkannt</strong></li>
    <li>âŒ Klassische Scores (GCS, APACHE) â†’ <strong>keine Echtzeit-Prognose</strong></li>
    <li>âŒ Ã„rzte handeln <strong>reaktiv</strong>, nicht <strong>prÃ¤ventiv</strong></li>
    <li class="highlight">âœ +30 % Re-Interventionen | +25 % MortalitÃ¤t <em>(JNS 2023)</em></li>
  </ul>
  <div class="chart-placeholder">ğŸ“‰ ICP-Kurve mit rotem â€Kipp-Punktâ€œ (zu spÃ¤t erkannt)</div>
  <p style="text-align:center; margin-top:20px;"><i class="fas fa-bell icon" style="color:var(--red);"></i> <strong>Zeit ist Hirn</strong></p>
</div>

<!-- FOLIE 3 -->
<div class="slide" id="slide3">
  <h1>Die LÃ¶sung: Neuroguard</h1>
  <h2 style="color:var(--blue-dark);">Ãœberlebenswahrscheinlichkeit â€“ <span class="highlight">6â€“12 Stunden im Voraus</span></h2>
  <ul>
    <li>âœ… KI-Plattform mit <strong>klinisch interpretierbaren</strong> Risikoindikatoren</li>
    <li>âœ… <strong>Echtzeit-Dashboard</strong> mit farbcodierten Profilen</li>
    <li>âœ… Integration: HL7, CSV, SPSS, API</li>
    <li>âœ… <strong>FrÃ¼hwarnung</strong> bevor Symptome auftreten</li>
  </ul>
  <div class="dashboard">
    <p><strong>Dashboard-Live-Ansicht:</strong></p>
    <p>ğŸ‘¤ <strong>Patient X</strong> â†’ <span class="risk-high">87 % Risiko in 8 Std.</span> <span class="badge badge-red">HOCH</span></p>
    <p>ğŸ‘¤ Patient Y â†’ <span class="risk-med">42 % Risiko</span> <span class="badge">MITTEL</span></p>
    <p>ğŸ‘¤ Patient Z â†’ <span class="risk-low">12 % Risiko</span> <span class="badge badge-green">NIEDRIG</span></p>
  </div>
</div>

<!-- FOLIE 4 -->
<div class="slide" id="slide4">
  <h1>Klinischer USP</h1>
  <p style="font-size:1.3rem; margin-bottom:20px;"><strong>Erste Plattform weltweit: Prognose <u>nur aus ICP-Daten</u></strong></p>
  <table>
    <tr><th>Feature</th><th>Neuroguard</th><th>Klassische Scores</th></tr>
    <tr><td>Echtzeit-Vorhersage</td><td>âœ… 6â€“12 Std.</td><td>âŒ Statisch</td></tr>
    <tr><td>Klinisch interpretierbar</td><td>âœ…</td><td>âŒ Blackbox</td></tr>
    <tr><td>FrÃ¼hwarnung</td><td>âœ… <strong>88 %</strong></td><td>âŒ</td></tr>
    <tr><td>AUC</td><td><strong>0.89</strong></td><td>0.65â€“0.72</td></tr>
  </table>
  <div class="chart-placeholder">ğŸ“Š ROC-Kurve mit <strong>AUC = 0.89</strong> hervorgehoben</div>
  <p class="quote">"Endlich eine Prognose, der ich vertraue." <br>â€” <em>Prof. Dr. M., Uniklinik ZÃ¼rich</em></p>
</div>

<!-- FOLIE 5 -->
<div class="slide" id="slide5">
  <h1>Klinische Validierung</h1>
  <p style="font-weight:600;">Pilotstudien: <strong>2 Zentren | 50 Patienten | 6 Monate</strong></p>
  <table>
    <tr><th>Metrik</th><th>Neuroguard</th><th>Klassische Scores</th></tr>
    <tr><td>FrÃ¼hwarnung ICP-Trends</td><td><strong>88 %</strong></td><td>42 %</td></tr>
    <tr><td>Re-Intervention-UnterstÃ¼tzung</td><td><strong>76 %</strong></td><td>51 %</td></tr>
    <tr><td>Reduktion unnÃ¶tiger CTs</td><td><strong>â€“34 %</strong></td><td>â€“</td></tr>
  </table>
  <div class="chart-placeholder">ğŸ“Š Balkendiagramm: Neuroguard vs. GCS/APACHE</div>
  <p class="quote">"Neuroguard erkennt, was wir Ã¼bersehen."</p>
</div>

<!-- FOLIE 6 -->
<div class="slide" id="slide6">
  <h1>Markt & Zielkunden</h1>
  <ul>
    <li><strong>TAM:</strong> 3,2 Mrd. USD (Neuro-ICU weltweit)</li>
    <li><strong>SAM (DACH+EU):</strong> 500 Mio. CHF</li>
    <li><strong>SOM (Jahr 3):</strong> 3 Mio. CHF bei 100 Kliniken</li>
  </ul>
  <h2 style="margin-top:25px;">Zielkunden:</h2>
  <ol>
    <li>UniversitÃ¤tskliniken</li>
    <li>Neurochirurgische Intensivstationen</li>
    <li>MedTech-Partner (API-Lizenz)</li>
  </ol>
  <div class="chart-placeholder">ğŸ—ºï¸ Karte: DACH + EU mit roten Punkten (Zielkliniken)</div>
  <p style="text-align:center; margin-top:15px;">ğŸ‡¨ğŸ‡­ Schweiz â†’ ğŸ‡©ğŸ‡ª Deutschland â†’ ğŸ‡ªğŸ‡º EU</p>
</div>

<!-- FOLIE 7 -->
<div class="slide" id="slide7">
  <h1>Wettbewerbsvorteil</h1>
  <table>
    <tr><th></th><th>Neuroguard</th><th>Wettbewerber A</th><th>Wettbewerber B</th></tr>
    <tr><td>Nur ICP-Daten</td><td>âœ…</td><td>âŒ</td><td>âŒ</td></tr>
    <tr><td>Interpretierbar</td><td>âœ…</td><td>Teilweise</td><td>âŒ</td></tr>
    <tr><td>Echtzeit-Dashboard</td><td>âœ…</td><td>âŒ</td><td>âœ…</td></tr>
    <tr><td>CE/MDR</td><td>In Planung</td><td>âœ…</td><td>âŒ</td></tr>
    <tr><td>AUC (validiert)</td><td><strong>0.89</strong></td><td>0.81</td><td>0.77</td></tr>
  </table>
  <p style="text-align:center; font-size:1.4rem; margin-top:25px; color:var(--blue-dark);">
    <strong>â€Weniger Daten. Mehr PrÃ¤zision.â€œ</strong>
  </p>
</div>

<!-- FOLIE 8 -->
<div class="slide" id="slide8">
  <h1>GeschÃ¤ftsmodell (SaaS)</h1>
  <p style="font-size:1.2rem; margin-bottom:20px;"><strong>Wiederkehrende Einnahmen â€“ 70 % Bruttomarge</strong></p>
  <ul>
    <li><strong>SaaS-Lizenz:</strong> 2.500 CHF / Monat / Klinik</li>
    <li><strong>API (MedTech):</strong> 10.000 CHF / Monat</li>
    <li><strong>Custom-Analysen:</strong> 5.000â€“15.000 CHF / Projekt</li>
  </ul>
  <h2 style="margin-top:20px;">Jahr 3:</h2>
  <p style="font-size:1.3rem; color:var(--blue-dark);"><strong>100 Kliniken â†’ 3 Mio. CHF ARR</strong></p>
  <div class="chart-placeholder">ğŸ’° Einnahmen-Fluss: Klinik â†’ SaaS â†’ API â†’ Forschung</div>
</div>

<!-- FOLIE 9 -->
<div class="slide" id="slide9">
  <h1>Entwicklungsstand & Roadmap</h1>
  <table>
    <tr><th>Meilenstein</th><th>Status</th><th>Q1 2026</th></tr>
    <tr><td>Prototyp + AUC-Reports</td><td>âœ…</td><td>â€“</td></tr>
    <tr><td>Patentanmeldung</td><td>In Vorbereitung</td><td>âœ…</td></tr>
    <tr><td>CE/MDR-Zertifizierung</td><td>In Planung</td><td>âœ…</td></tr>
    <tr><td>Multicenter-Studie (200 Pat.)</td><td>â€“</td><td>âœ…</td></tr>
  </table>
  <div class="chart-placeholder">â³ Timeline mit grÃ¼nen Haken</div>
  <p style="text-align:center; margin-top:15px;"><i class="fas fa-stethoscope icon"></i> + <i class="fas fa-microchip icon"></i></p>
</div>

<!-- FOLIE 10 -->
<div class="slide" id="slide10">
  <h1>Investmentbedarf</h1>
  <p style="font-size:1.4rem; color:var(--blue-dark);"><strong>1,2 Mio. CHF Seed</strong></p>
  <table>
    <tr><th>Verwendung</th><th>Anteil</th><th>Betrag</th></tr>
    <tr><td>Zertifizierung & Studie</td><td>40 %</td><td>480k</td></tr>
    <tr><td>KI & Plattform</td><td>30 %</td><td>360k</td></tr>
    <tr><td>Business Development</td><td>20 %</td><td>240k</td></tr>
    <tr><td>IP & Recht</td><td>10 %</td><td>120k</td></tr>
  </table>
  <div class="chart-placeholder">ğŸ“Š Kreisdiagramm Kapitalverteilung</div>
  <p style="margin-top:20px; color:var(--blue-dark);"><strong>ROI:</strong> Break-even Monat 30 | 5x bei Exit</p>
</div>

<!-- FOLIE 11 -->
<div class="slide" id="slide11">
  <h1>Skalierbarkeit & Exit</h1>
  <p style="font-size:1.2rem;"><strong>Skalierbar auf 500+ Kliniken weltweit</strong></p>
  <ul>
    <li><strong>Jahr 3:</strong> 100 Kliniken â†’ <strong>3 Mio. CHF ARR</strong></li>
    <li><strong>Jahr 5:</strong> 300 Kliniken â†’ <strong>9 Mio. CHF ARR</strong></li>
    <li><strong>Exit:</strong> Ãœbernahme durch Siemens, Medtronic, Philips</li>
    <li><strong>Series A Bewertung:</strong> 8â€“10 Mio. CHF (2027)</li>
  </ul>
  <div class="chart-placeholder">ğŸ“ˆ Wachstumskurve + Pfeil â†’ â€EXITâ€œ</div>
</div>

<!-- FOLIE 12 -->
<div class="slide" id="slide12">
  <h1>Vision & Team</h1>
  <p class="quote" style="font-size:1.3rem;">"Von reaktiver Medizin zu <strong>proaktiver PrÃ¤vention</strong>."</p>
  <h2 style="margin-top:30px; color:var(--blue-dark);">Vision:</h2>
  <p style="font-size:1.3rem; margin:15px 0;"><strong>Neuroguard wird Standard in jeder Neuro-ICU weltweit.</strong></p>
  <h2 style="margin-top:30px;">Team:</h2>
  <p><strong>Cemalettin G.</strong> â€“ Founder & CEO<br><em>Ex-Neurochirurg, Uniklinik ZÃ¼rich, 8 Jahre ICP-Forschung</em></p>
  <p style="margin-top:15px;"><strong>Oktay T.</strong> â€“ Co-Founder & CTO<br><em>KI-Engineer, ETH ZÃ¼rich, 3 Patente in ML-Medizin</em></p>
  <p style="text-align:center; margin-top:40px; font-size:1.4rem; color:var(--blue-dark);">
    <strong>â€Wir schÃ¼tzen das Gehirn â€“ bevor es zu spÃ¤t ist.â€œ</strong>
  </p>
  <div style="text-align:center; margin-top:30px; font-size:2rem;">
    <i class="fas fa-brain" style="color:var(--blue);"></i>
  </div>
</div>

<div class="footer">
  <p>Â© 2025 Neuroguard | <a href="mailto:cemalettin@neuroguard.ai" style="color:var(--blue);">Kontakt aufnehmen</a> | <strong>Strg+P â†’ Als PDF speichern</strong></p>
</div>

</div>

<script>
  // Smooth scroll
  document.querySelectorAll('a[href^="#"]').forEach(anchor => {
    anchor.addEventListener('click', function (e) {
      e.preventDefault();
      document.querySelector(this.getAttribute('href')).scrollIntoView({
        behavior: 'smooth'
      });
    });
  });
</script>

</body>
</html>
